News | January 17, 2025
AbbVie partners with Simcere Zaiming to develop Novel Trispecific Antibody Candidate in Multiple Myeloma
SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3
SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3
The FDA determined that the data presented in a 2022 color additive petition show that this ingredient causes cancer in male laboratory rats exposed to high levels of FD&C Red No. 3 because of a hormonal mechanism that occurs in male rats
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Subscribe To Our Newsletter & Stay Updated
